Chest Computed Tomography (CT) Screening Study With Antibody Testing

Lung Cancer Clinical Trial

Official title:

Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01203579
• Other study ID #: 10-003048
• Status: Withdrawn
• Phase: N/A
• First received: September 15, 2010
• Last updated: June 20, 2012
• Start date: September 2011
• Est. completion date: September 2011

Study information

• Verified date: June 2012
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

Description:

EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: September 2011
• Est. primary completion date: September 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 50 Years to 75 Years

Eligibility

• Persons 50-75

• Asymptomatic for lung cancer

• Current or former (stopped smoking less than 10 years ago) cigarette smokers

• History of cigarette smoking of at least 20 pack years

• History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).

• Mentally competent individuals to sign an informed consent.

• Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.

• A fully informed signed consent form must have been obtained.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States,